Skip to main content
Premium Trial:

Request an Annual Quote

Cepheid Signs Group Purchasing Deal with Premier

NEW YORK (GenomeWeb News) – Cepheid said today that it has signed a group purchasing contract with Premier, a group purchasing organization that has more than 1,500 hospitals in its network.
 
The Sunnyvale, Calif.-based molecular diagnostics firm also said that it has signed a preferred vendor pact with the Western North Carolina Health Network. The WNCHN includes 53 acute care hospitals that use Premier as their GPO.
 
According to Cepheid, the agreements will enable Premier and WNCHN customers to purchase the firm’s GeneXpert multiplex platform and Xpert methicilllin-resistant Staphylococcus aureus tests at pre-negotiated prices.
 
Further details were not disclosed.
 
Cepheid's revenues have been increasingly shifting to the general hospital market, after its initial revenue base was built on sales to the Veterans Administration network of hospitals. Two weeks ago, the firm reported first-quarter revenue growth of 76 percent.
 

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.